Want to see AU:MSX full AI Analyst Report?
Neuroscientific Biopharmaceuticals Ltd. (MSX) Income Statement
Neuroscientific Biopharmaceuticals Ltd. Income Statement
Last quarter (Q4 2026), Neuroscientific Biopharmaceuticals Ltd.'s total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q4, Neuroscientific Biopharmaceuticals Ltd.'s net income was $-2.99M. See Neuroscientific Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 2.21M | $ 4.95M | $ 0.00 | |
| $ -1.38M | $ -92.78K | $ -91.34K | $ -57.85K | $ -64.92K | |
| $ 3.72M | $ 1.92M | $ 1.97M | $ 6.07M | $ 10.44M | |
| Depreciation and Amortization | $ 1.38M | $ 92.78K | $ 91.34K | $ 57.85K | $ 64.92K |
| $ -3.72M | $ -1.92M | $ -1.80M | $ -5.96M | $ -10.37M | |
| $ -5.11M | $ -1.92M | $ -2.06M | $ -6.12M | $ -10.50M | |
| $ 12.14K | $ 163.62K | $ 168.94K | $ 102.80K | $ 68.45K | |
| $ -5.10M | $ -1.85M | $ -1.89M | $ -6.02M | $ -10.44M | |
| $ -4.69M | $ -1.85M | $ 324.21K | $ -1.07M | $ -10.44M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.01 | $ 0.00 | $ -0.01 | $ -0.07 |
| Diluted EPS | $ -0.01 | $ -0.01 | $ 0.00 | $ -0.01 | $ -0.07 |
| Weighted Average Shares Outstanding | 337.27M | 146.47M | 144.51M | 143.47M | 143.47M |
| Weighted Average Shares Outstanding (Diluted) | 337.27M | 146.66M | 144.51M | 143.47M | 143.47M |
Currency in AUD
